• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Skyepharma PLC

+ Add to Watchlist

SKP:LN

222.000 GBp 13.000 6.22%

As of 06:26:51 ET on 04/17/2014.

Snapshot for Skyepharma PLC (SKP)

Open: 213.750 Day's Range: 212.750 - 222.000 Volume: 319,323
Previous Close: 209.000 52wk Range: 38.171 - 239.750 1-Yr Rtn: +452.67%

Stock Chart for SKP

No chart data available.
  • SKP:LN 222.000
  • 1D
  • 1M
  • 1Y
209.000
Interactive SKP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKP

Current P/E Ratio (ttm) 133.3021
Estimated P/E(12/2014) 13.8312
Relative P/E vs. UKX 7.8563
Earnings Per Share (GBP) (ttm) 0.0160
Est. EPS (GBP) (12/2014) 0.1540
Est. PEG Ratio -
Market Cap (M GBP) 122.77
Shares Outstanding (M) 46.13
30 Day Average Volume 452,616
Price/Book (mrq) -
Price/Sale (ttm) 1.8417
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKP

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SKP

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter W GrantChief Executive OfficerAndrew DerodraCFO/Executive Director
John MurphySecretary/General Counsel
More Company Profile & Key Executives for SKP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil